Assignee
OPPILAN PHARMA LTD
GB·1 granted patent·7 pending applications·0 citations·filing 2016–2025
Top patents by PatentIndex Score
8 records- 0177US2023339944A1Heterocyclic compounds for the treatment of diseaseOPPILAN PHARMA LTD·Filed 2023·Application pending·0 cites
- 0276US2026092064A1Heterocyclic compounds for the treatment of diseaseOPPILAN PHARMA LTD·Filed 2025·Application pending·0 cites
- 0371US2022227767A1Heterocyclic compounds for the treatment of diseaseOPPILAN PHARMA LTD·Filed 2022·Application pending·0 cites
- 0463US2020325135A1Heterocyclic compounds for the treatment of diseaseOPPILAN PHARMA LTD·Filed 2020·Application pending·0 cites
- 0561US10683291B2Heterocyclic compounds for the treatment of diseaseOPPILAN PHARMA LTD·Filed 2016·Granted Jun 16, 2020·0 cites·14 claims
- 0658US2024010649A1Crystalline forms of an s1p receptor modulatorOPPILAN PHARMA LTD·Filed 2023·Application pending·0 cites
- 0735US2021163485A1Heterocyclic Compounds for the Treatment of DiseaseOPPILAN PHARMA LTD·Filed 2018·Application pending·0 cites
- 0835US2020071327A1Prodrugs for the Treatment of DiseaseOPPILAN PHARMA LTD·Filed 2018·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when OPPILAN PHARMA LTD files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Counts cover granted patents and pending applications in the PatentIndex corpus. How scoring works →